Who owns Elicio Therapeutics Inc Com?

Tip: Access positions for across all investors

Analyze quarterly positions in Elicio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Elicio Therapeutics stock

Who bought or sold Elicio Therapeutics Inc Com this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 246k $1.2M 0% Dec 2024
 View chart
Geode Capital Management 71k $347k -1% Dec 2024
 View chart
CM Management 40k $204k -20% Dec 2024
 View chart
Northern Trust 31k $157k 0% Dec 2024
 View chart
State Street Corporation 22k $107k 0% Dec 2024
 View chart
BlackRock 20k $101k 1% Dec 2024
 View chart
Meyer Handelman 14k $71k 0% Dec 2024
 View chart
Atlantic Trust 7.0k $43k 0% Dec 2024
 View chart
Steward Partners Investment Advisory 1.6k $7.9k 0% Dec 2024
 View chart
Bank of America Corporation 1.2k $6.1k -3% Dec 2024
 View chart
National Bank Of Canada /fi/ 800.00 $4.0k -47% Sep 2024
 View chart
Tower Research Capital 611.00 $3.1k -36% Dec 2024
 View chart
Citigroup 374.00 $1.8k 0% Dec 2024
 View chart
Morgan Stanley 230.00 $1.2k -4% Dec 2024
 View chart
SBI Securities 83.00 $423.001200 100% Dec 2024
 View chart
Bnp Paribas Arbitrage, Snc 65.00 $332.000500 100% Dec 2024
 View chart
Jpmorgan Chase & Co 18.00 $88.000200 0% Dec 2024
 View chart
UBS Group 17.00 $86.999200 -98% Dec 2024
 View chart

Who sold out of Elicio Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Sep 2024 13k $65k
Bridgeway Capital Management Sep 2024 13k $63k